Portolan Capital Management - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,109,772
-41.7%
132,850
-27.1%
0.57%
-38.4%
Q2 2023$10,473,505
-18.0%
182,243
-46.5%
0.93%
-23.8%
Q1 2023$12,772,238
+68.3%
340,593
+25.8%
1.22%
+61.6%
Q4 2022$7,587,564
-4.3%
270,791
-4.0%
0.75%
-10.1%
Q3 2022$7,929,000
-17.1%
282,187
+2.7%
0.84%
-13.0%
Q2 2022$9,563,000274,8890.96%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders